Literature DB >> 35988101

The role and regulation of apoptosis signal-regulated kinase 1 in liver disease.

Yining Lu1, Yanning Liu1, Min Zheng2.   

Abstract

ASK1, also known as MAP3K5, plays a vital role in the MAPK pathway. The MAPK pathway has a variety of biological functions and plays an important role in regulating cell proliferation, differentiation, and apoptosis. Studies have shown that ASK1 is involved in apoptosis, inflammation, oxidative stress, and other processes and plays an essential role in various liver diseases. Therefore, ASK1 can be a therapeutic target for treating liver disease. Here, we initially summarized the effect of ASK1 on liver disease and described the differential regulation of ASK1, including phosphorylation, ubiquitination and methylation, by which the effects of ASK1 on some liver diseases can be inhibited. Although much has been discovered about the phosphorylation of ASK1, the effects of other post-transcriptional modifications on the activity of ASK1 require further exploration. We hope that by summarizing the existing regulatory mechanism we can shed new light on the research and provide new ideas for finding ASK1-targeting drugs.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  ASK1; Liver diseases; Methylation; Phosphorylation; Ubiquitination

Year:  2022        PMID: 35988101     DOI: 10.1007/s11033-022-07783-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  50 in total

1.  ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.

Authors:  Grant R Budas; Mario Boehm; Baktybek Kojonazarov; Gayathri Viswanathan; Xia Tian; Swathi Veeroju; Tatyana Novoyatleva; Friedrich Grimminger; Ford Hinojosa-Kirschenbaum; Hossein A Ghofrani; Norbert Weissmann; Werner Seeger; John T Liles; Ralph T Schermuly
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

2.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

Authors:  K Tobiume; A Matsuzawa; T Takahashi; H Nishitoh; K Morita ; K Takeda; O Minowa; K Miyazono; T Noda; H Ichijo
Journal:  EMBO Rep       Date:  2001-03       Impact factor: 8.807

3.  Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.

Authors:  Mei Xiang; Pi-Xiao Wang; Ai-Bing Wang; Xiao-Jing Zhang; Yaxing Zhang; Peng Zhang; Fang-Hua Mei; Man-Hua Chen; Hongliang Li
Journal:  J Hepatol       Date:  2016-02-06       Impact factor: 25.083

4.  Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinases.

Authors:  Sarah J Trevelyan; Jodi L Brewster; Abigail E Burgess; Jennifer M Crowther; Antonia L Cadell; Benjamin L Parker; David R Croucher; Renwick C J Dobson; James M Murphy; Peter D Mace
Journal:  Sci Signal       Date:  2020-03-10       Impact factor: 8.192

Review 5.  Apoptosis signal-regulating kinase 1 in stress and immune response.

Authors:  Kohsuke Takeda; Takuya Noguchi; Isao Naguro; Hidenori Ichijo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 6.  Decoding cell death signals in liver inflammation.

Authors:  Catherine Brenner; Lorenzo Galluzzi; Oliver Kepp; Guido Kroemer
Journal:  J Hepatol       Date:  2013-04-06       Impact factor: 25.083

7.  Effects of Selonsertib in Patients with Diabetic Kidney Disease.

Authors:  Glenn M Chertow; Pablo E Pergola; Fang Chen; Brian J Kirby; John S Sundy; Uptal D Patel
Journal:  J Am Soc Nephrol       Date:  2019-09-10       Impact factor: 10.121

8.  Damage sensing by a Nox-Ask1-MKK3-p38 signaling pathway mediates regeneration in the adult Drosophila midgut.

Authors:  Parthive H Patel; Clothilde Pénalva; Michael Kardorff; Marianne Roca; Bojana Pavlović; Anja Thiel; Aurelio A Teleman; Bruce A Edgar
Journal:  Nat Commun       Date:  2019-09-25       Impact factor: 14.919

9.  The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.

Authors:  Rohit Loomba; Eric Lawitz; Parvez S Mantry; Saumya Jayakumar; Stephen H Caldwell; Hays Arnold; Anna Mae Diehl; C Stephen Djedjos; Ling Han; Robert P Myers; G Mani Subramanian; John G McHutchison; Zachary D Goodman; Nezam H Afdhal; Michael R Charlton
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

10.  ASK1 inhibits browning of white adipose tissue in obesity.

Authors:  Fabrizio C Lucchini; Stephan Wueest; Tenagne D Challa; Flurin Item; Salvatore Modica; Marcela Borsigova; Yulia Haim; Christian Wolfrum; Assaf Rudich; Daniel Konrad
Journal:  Nat Commun       Date:  2020-04-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.